BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Discovery of BCR-ABL1 fusion in CML served as evidence of clonality in this disease and led to a vigorous search for clonal molecular markers in the “Philadelphia chromosome negative” (Ph-) MPNs.